Best Practice Guideline articleTherapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy
Section snippets
Clinical evidence supporting therapeutic hypothermia in newborns
Clinical studies of therapeutic hypothermia were based on the successful experimental studies and mostly utilized a similar therapeutic approach: a reduction in brain or body temperature by 3–4 °C for up to 72 h started within 6 h of birth. Studies used either selective head cooling (with mild whole body cooling) or whole body cooling methods using purposely designed cooling equipment or simply by placing cold bags around the body of the infant [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]
Mechanism of action of therapeutic hypothermia
The precise mechanism of neural rescue by moderate hypothermia is uncertain but may be related to the critical relationship between temperature and metabolic rate: for every 1 °C lowering of the core temperature cerebral metabolism is reduced by approximately 7%, with consequently a lower glucose and oxygen demand [28]. Both necrotic and apoptotic mechanisms are implicated in neuronal injury following neonatal hypoxia ischaemia and reperfusion [29]. Mitochondrial injury leads to energy failure,
Clinical application of therapeutic hypothermia
Current advice from national specialist bodies is that therapeutic hypothermia should only be provided according to the protocols used in the clinical trials [38], [39]. However, in view of the strength of the evidence supporting therapeutic hypothermia and the lack of serious adverse effects, it is not surprising that clinicians may wish to consider therapeutic hypothermia in other infants with clinical criteria that differ from those of the trial protocols, such as infants less than 36 weeks
Which infants should be considered for treatment with cooling?
The major clinical trials had similar eligibility criteria: infants were at least 36 weeks gestation, had profound depression at birth (Apgar score ≤ 5 at 10 min) or severe metabolic acidosis (pH < 7.0) and moderate or severe encephalopathy, although definitions differed slightly amongst trials. In two trials an abnormal amplitude integrated EEG was also required [20], [22]. Despite these differences the major randomized trials had remarkably similar outcomes and point estimates of treatment effect.
Therapeutic hypothermia in infants born outside treatment centres
In the majority of infants hypoxic ischaemic encephalopathy occurs unexpectedly following an uncomplicated pregnancy or following a complication occurring just before delivery. Therefore, many infants will be born in hospitals or in locations without resources for providing intensive care and therapeutic hypothermia. Experimental evidence suggests that the therapeutic response is diminished the later hypothermia is started so early assessment and initiation of therapeutic hypothermia is vital.
Therapeutic hypothermia in cooling centres
Early identification and assessment of newborns for evidence of hypoxic ischaemic encephalopathy and seizures are crucial. Passive cooling should be commenced in a controlled way as soon as possible after resuscitation is completed if the perinatal history is strongly suggestive for hypoxic ischaemic encephalopathy. Once the eligibility criteria are met active cooling preferably using certified cooling equipment can be commenced. In our experience the amplitude integrated EEG aids clinical
Assessment of prognosis following therapeutic hypothermia
A major challenge in the clinical care of infants with severe hypoxic ischaemic encephalopathy is the assessment of prognosis, which is vitally important for directing clinical management. It is often difficult to assess the therapeutic response to hypothermia during the first few days after birth, perhaps because routine use of sedation often in combination with large doses of anticonvulsants hinders clinical assessment. Although the clinical severity of encephalopathy correlates with
Conclusion
Therapeutic hypothermia for neonates with hypoxic ischaemic encephalopathy is rapidly being introduced into routine clinical practice. Clinical management should closely follow the published protocols but may need to be altered according to individual circumstances. The results of on-going studies may further refine the therapeutic approach. Continued surveillance of the use of therapeutic hypothermia in clinical practice is necessary to detect unusual complications and audit practice.
References (57)
- et al.
Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial
J Pediatr
(1986) - et al.
Selective head cooling with hypothermia suppresses the generation of platelet-activating factor in cerebrospinal fluid of newborn infants with perinatal asphyxia
Prostaglandins Leukot Essent Fatty Acids
(2003) - et al.
Moderate hypothermia in neonatal encephalopathy: efficacy outcomes
Pediatr Neurol
(2005) - et al.
Moderate hypothermia in neonatal encephalopathy: safety outcomes
Pediatr Neurol
(2005) - et al.
Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial
Lancet
(2008) - et al.
Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial
Lancet
(2005) - et al.
The ‘pharmacology’ of neuronal rescue with cerebral hypothermia
Early Hum Dev
(1998) - et al.
Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia
Biochem Biophys Res Commun
(1995) Do seizures contribute to neonatal hypoxic-ischemic brain injury?
J Pediatr
(2009)- et al.
Neonatal seizures: multicenter variability in current treatment practices
Pediatr Neurol
(2007)
“Therapeutic time window” duration decreases with increasing severity of cerebral hypoxia-ischaemia under normothermia and delayed hypothermia in newborn piglets
Brain Res
Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial
Lancet Neurol
Randomized trial of systemic hypothermia selectively protects the cortex on MRI in term hypoxic-ischemic encephalopathy
J Pediatr
Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia
Arch Dis Child Fetal Neonatal Ed
The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants
Dev Med Child Neurol
Hypothermia in the treatment of asphyxia neonatorum
Biol Neonat
Neonatal asphyxia pallida treated with hypothermia alone or with hypothermia and transfusion of oxygenated blood
Surgery
Selective head cooling in newborn infants after perinatal asphyxia: a safety study
Pediatrics
Induced brain hypothermia in asphyxiated human newborn infants: a retrospective chart analysis of physiological and adverse effects
Intensive Care Med
Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy
Pediatrics
Pilot study of treatment with whole body hypothermia for neonatal encephalopathy
Pediatrics
Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants
Pediatrics
Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia
Pediatrics
Mild hypothermia via selective head cooling as neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal intensive care unit
J Perinatol
Evaluating a simple method of neuroprotective hypothermia for newborn infants
J Trop Pediatr
Induced hypothermia for infants with hypoxic-ischemic encephalopathy using a servo-controlled fan: an exploratory pilot study
Pediatrics
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy
N Engl J Med
Cited by (38)
Combined therapy in neonatal hypoxic-ischaemic encephalopathy
2019, Anales de PediatriaPregnancy as a valuable period for preventing hypoxia-ischemia brain damage
2018, International Journal of Developmental NeuroscienceCitation Excerpt :Current therapeutic approaches employed in the clinical settings are very limited and available treatments to newborn infants focus on supportive care, such as controlling hypoglycemia, treatment of convulsions and associated infections. The gold standard is hypothermia started within 6 h after birth, however it is used only in a small percentage of term (or near term) infants (McKenna et al., 2015; Roka and Azzopardi, 2010). This review aims to present evidence that pregnancy is a valuable period for preventing hypoxia-ischemia brain damage.
Mitochondrial dysfunction in perinatal asphyxia: role in pathogenesis and potential therapeutic interventions
2021, Molecular and Cellular Biochemistry